The Challenge Galderma Group AG (SIX: GALD) is a global leader in dermatology, headquartered in Zug, Switzerland, with a newly announced U.S. headquarters in Miami. Its portfolio spans three high-growth areas: Injectable Aesthetics (Restylane, Dysport/Azzalure/Alluzience, Sculptra), Dermatological Skincare (Cetaphil, Alastin), and Therapeutic Dermatology (Differin, Epiduo, Soolantra, Oracea). Listed on the SIX Swiss Exchange in March The post Case Study: Finding the Right CFO for Galderma’s...
